SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Srinivasa Ramanujan

PatientSrinivasa Ramanujan
Date of birth1996-12-22
IdentifiersMRN HR-ET020-SYN; SSN (made up) 000-20-1937
Document date2026-04-20
AuthorEdmund Ashworth, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Three months: abscess treatment complete, rifampin month two, blood count, liver tests, vitamins, mood, and plans to visit home. [S]

History of Present Illness

Mr. Ramanujan returns two weeks after his preventive visit. He has had no fever, pain, night sweats or diarrhea since the cold a month ago, and his weight is close to what it was before he fell ill. He is two months into rifampin, with no missed doses, nausea, rash or yellowing. He takes vitamin B12 and vitamin D daily. His hepatitis A antibody was positive, so he needs no vaccine for the trip, and the travel clinic has given him advice on malaria and food. He still sees the counselor, now every two weeks, calls home each Sunday, and has offered to teach a mathematics class at the Tamil association. He leaves for India in the summer and will take enough rifampin to finish the course there. [S]

ElementDetail
SymptomsNone
RifampinTwo months of four; no side effects
TravelHepatitis A immune; travel clinic seen; typhoid vaccine given
MoodPHQ-9 5

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or sweats; weight nearly back to before the illness
GastrointestinalNegativeNo pain, nausea or diarrhea
EyesNegativeOrange tears only; no yellowing
IntegumentaryNegativeNo rash
PsychiatricNegativeMood much better; no thoughts of self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metronidazole 250 mg oral tablet, three tablets (750 mg) three times a day with food for 10 daysThree tablets every 8 hours with food for 10 daysOral route2026-01-14 to 2026-01-23completedS
Paromomycin 250 mg oral capsule, two capsules (500 mg) three times a day with meals for 7 days, started the day after metronidazole endsTwo capsules every 8 hours with meals for 7 daysOral route2026-01-24 to 2026-01-30completedS
Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet dailyOne tablet dailyOral route2026-01-14activeS
Cholecalciferol 50,000 unit (1.25 mg) oral tablet, one tablet once a week for 8 weeksOne tablet once a week for 8 weeksOral route2026-01-14 to 2026-03-04completedS
Cholecalciferol 2,000 unit (50 microgram) oral tablet, one tablet daily, from the end of the weekly courseOne tablet dailyOral route2026-03-05activeS
Rifampin 300 mg oral capsule, two capsules (600 mg) once daily on an empty stomach for 4 monthsTwo capsules each morning before breakfast for 4 monthsOral route2026-02-23activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-04-20Body height165cmS
2026-04-20Body weight56.6kgS
2026-04-20Body mass index (BMI) [Ratio]20.8kg/m2S
2026-04-20Systolic blood pressure118mm[Hg]S
2026-04-20Diastolic blood pressure74mm[Hg]S
2026-04-20Heart rate70/minS
2026-04-20Respiratory rate14/minS
2026-04-20Body temperature36.6CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-20Leukocytes [#/volume] in Blood by Automated count6.210*3/uL4-11 10*3/uLNormalS
2026-04-20Hemoglobin [Mass/volume] in Blood13.8g/dL13.2-17.1 g/dLNormalS
2026-04-20MCV [Entitic mean volume] in Red Blood Cells by Automated count90fL80-100 fLNormalS
2026-04-20Platelets [#/volume] in Blood by Automated count26210*3/uL150-400 10*3/uLNormalS
2026-04-20C reactive protein [Mass/volume] in Serum or Plasma2mg/L<=5 mg/LNormalS
2026-04-20Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma96U/L40-129 U/LNormalS
2026-04-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma30U/L7-41 U/LNormalS
2026-04-20Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma26U/L10-40 U/LNormalS
2026-04-20Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.1-1.2 mg/dLNormalS
2026-04-20Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma520pg/mL232-1245 pg/mLNormalS
2026-04-2025-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma32ng/mL30-100 ng/mLNormalS
2026-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-04-20Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]4{score}S

Physical Exam

Vital signs recorded on 2026-04-20; see the Vital Signs section. [S]

SystemFinding
GeneralWell; temperature 36.6 °C, pulse 70; weight 56.6 kg
AbdomenLiver not enlarged or tender
SkinNo rash or jaundice
PsychiatricWarm and engaged; smiles when he talks about the class he will teach

Problems

ProblemClinical statusVerificationCodeProvenance
Evening fevers to 38.6 °C with night sweats for about four weeksresolvedconfirmed R50.9S — Synthetic presenting symptom, superseded by the diagnosis at the second visit.
Weight loss of 5 kg over two months (57 to 52 kg), with poor appetiteresolvedconfirmed R63.4S — Synthetic presenting symptom, superseded by the diagnosis at the second visit.
Dull right upper quadrant pain for three weeks, worse on deep breathing and lying on the right side, with a tender liver edgeresolvedconfirmed R10.11S — Synthetic presenting symptom, superseded by the diagnosis at the second visit.
Amebic liver abscess: a single 6.2 x 5.4 cm abscess in the right lobe (segment VII) on ultrasound, Entamoeba histolytica antibody positive, blood cultures negative, years after two episodes of dysentery in India; treated with metronidazole and then paromomycin; synthetic modern diagnosis linked to the hepatic amoebiasis later proposed for his illnessresolvedconfirmed A06.4S — Synthetic modern diagnosis; it does not settle the historical diagnostic conflict (CLM-0010, CLM-0011).
Vitamin B12 deficiency from a strict vegetarian diet (B12 168 pg/mL), with anemia (hemoglobin 11.2 g/dL, MCV 99 fL) to which inflammation also contributesactiveconfirmed D51.3S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed.
Vitamin D deficiency (25-hydroxyvitamin D 9 ng/mL)activeconfirmed E55.9S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed.
Positive interferon-gamma release assay, with chest radiograph and sputum smears and NAAT negative for tuberculosis; cultures pendingresolvedconfirmed R76.12S — Synthetic finding, superseded by the diagnosis of latent infection when cultures were negative.
Latent tuberculosis infection: positive interferon-gamma release assay, normal lungs on the radiograph, three sputum smears, NAAT and cultures negative; treated with four months of rifampinactiveconfirmed Z22.7S — Synthetic modern diagnosis; active tuberculosis was excluded, which does not settle the historical question.
Adjustment disorder with depressed mood (PHQ-9 12, no thoughts of self-harm) during a serious illness, far from his wife and familyactiveconfirmed F43.21S — Synthetic modern diagnosis anchored to his documented loneliness; not a claim about his real mental health.
Acute viral upper respiratory infection, three weeks into rifampin and six weeks after treatment of the liver abscess, without signs of abscess relapse; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationTemperature, symptoms and abdominal examination (liver tenderness, right lower rib tenderness)Every visitCompleted todayNo fever; liver not tender
ExaminationWeight and BMIEvery visitCompleted today56.6 kg, up 4.6 kg since intake
LaboratoryBlood count and C-reactive proteinAt diagnosis, at the end of the tissue course, then until normalCompleted todayWhite cells 6.2, hemoglobin 13.8, MCV 90, platelets 262; CRP 2 mg/L
LaboratoryLiver tests (alkaline phosphatase, ALT, AST, bilirubin, albumin)At diagnosis, at the end of therapy, and before and during rifampinCompleted todayAlkaline phosphatase 96, ALT 30, AST 26 U/L, bilirubin 0.7 mg/dL on rifampin
ImagingLiver imagingAt diagnosis; repeat only for no response or a complicationNot indicatedRecovered; no repeat imaging
Medication safetyRifampin safety and adherence (nausea, rash, jaundice, missed doses, drug interactions)Monthly clinical check; liver tests at baseline and as indicatedCompleted todayTwo months; no missed doses or side effects; supply for travel arranged
LaboratoryResponse to vitamin B12 replacementReticulocyte count at 1 week; blood count at about 8 weeks; neurologic examination at diagnosisCompleted todayBlood count normal at about three months; B12 520 pg/mL
Laboratory25-hydroxyvitamin DAt diagnosis; after repletionCompleted today32 ng/mL after repletion
Self-managementDiet and weight plan within his vegetarian rulesEvery visitCompleted todayTwo meals a day within his rules; weight nearly regained
SurveyPHQ-9 and GAD-7At least monthly while symptoms are activeCompleted todayPHQ-9 5, GAD-7 4
SurveySuicide-risk review, safety plan and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; a crisis contact for India added to the safety plan for the trip
Self-managementSupport far from home (counseling, contact with family and community, department and fellowship)Every visitCompleted todayCounseling every two weeks; calls home; teaching a class in his community

Goal progress:

Guideline basis: Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 (2020); DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026); A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis (2018); Position of the Academy of Nutrition and Dietetics: Vegetarian Diets (2016); CMID: Clinical Monitoring Intelligence Database, anemia and depression monographs (2026); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)

Follow-up: Second hepatitis B dose before he travels. Completion of rifampin, by video from India if needed. Review on his return with vitamin D, a lipid panel and mood. Seek care promptly for fever or right-sided pain while away. [S]